<unk>  refers to a regimen consisting of idarubicin, cytarabine (Ara-C), and cladribine used to treat acute myelogenous leukemia.
IAC regimen
FMC regimen
IFL regimen
MOPP regimen
CNOP regimen
COPP regimen
FMR regimen
GVD regimen